Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, November 26, 2019

Here's Why Drugs That Work So Well in Mouse Brains Often Fail Miserably in Humans

So our stroke leadership should identify which research needs to be redone. But since we have NO STROKE LEADERSHIP, nothing will occur. 

Did your stroke leadership do anything with this from last year?

Drugs That Work In Mice Often Fail When Tried In People Sept. 2018

 These are probably the candidates needing rework, your doctor should be able to instantly identify them all if they are up-to-date in stroke research.  

Well, years ago Dr. Michael Tymianski of the Toronto Western Hospital Research Institute in Canada referenced 1000+ failed neuroprotective clinical trials. Of course I don't know what they are, but your doctor should know every one of those failed trials.

Here's Why Drugs That Work So Well in Mouse Brains Often Fail Miserably in Humans




Neuroscientists face a major obstacle in developing drugs to treat brain disorders — if the drugs work really well on mice, they often fall short when humans are treated. Now, a new study suggests a potential reason why:  Brain cells in mice turn on genes that are very different from the ones in human brain cells.
Mice and humans have evolutionarily conserved brains, meaning they have very similar brain architectures made up of similar types of brain cells. In theory, that makes mice ideal test subjects for neuroscientists, who don't typically have the ability to peer into living human brains.




Yet for mysterious reasons, treatments that worked beautifully in the mouse brain often don't pan out when tested in humans. 
To figure out why that may be, a group of scientists from the Allen Institute for Brain Science in Seattle analyzed brains donated from deceased people and brain tissue donated by epilepsy patients after brain surgery. They specifically looked at a part of the brain called the medial temporal gyrus, which is involved in language processing and deductive reasoning.
Researchers sorted through nearly 16,000 cells from this brain region and identified 75 different cell types. When they compared the human cells with a data set of mouse cells, they found that mice had counterparts that were similar to almost all of those human brain cells.
But when they looked at which genes were switched on or off inside those cells, they found stark differences between the mouse and human cells.
For example, serotonin is a neurotransmitter — or brain chemical — that regulates appetite, mood, memory and sleep. It does so by binding to brain cells via a receptor on the cell surface, which acts like a glove that is made to catch a baseball.
But a mouse's serotonin receptors are not found on the same cells that they're found in humans, the researchers discovered. So a drug that increases serotonin levels in the brain, such as those used to treat depression, might deliver it to vastly different cells in mice than in humans.
They also found differences in the expression of genes that help build connections between neurons. In essence, the cellular roadmap in our brains may look very different from what it looks like in a mouse.
"The bottom line is there are great similarities and differences between our brain and that of the mouse," co-senior author Christof Koch, the chief scientist and president of the Allen Institute for Brain Science, said in a statement. "One of these tells us that there is great evolutionary continuity, and the other tells us that we are unique."
"If you want to cure human brain diseases, you have to understand the uniqueness of the human brain," he added. The findings were published yesterday (Aug. 21) in the journal Nature.
Originally published on Live Science.

No comments:

Post a Comment